Development and Validation of a Stability-indicating RP-HPLC Method for the Estimation of Eltrombopag in Bulk and Tablet Formulation
Asian Journal of Chemical Sciences · pp. 1–9 · Published 7 Apr 2018
10.9734/AJOCS/2018/40542Abstract
Aims: A simple, gradient RP- HPLC method has been developed and validated for Eltrombopag in bulk and tablet formulation. Methodology: The method was validated to meet official requirements including selectivity, stability, linearity, precision and accuracy. Successful estimation was carried out for the drug product was developed on C(18) column reversed-phase using acetonitrile: methanol: water in the ratio (55:35:10 %. v/v) as mobile phase composition. The flow rate was adjusted to 1ml /minute and the absorption maxima were observed at 230 nm utilizing Shimadzu SPD-20A Prominence UV-Visible detector. Eltrombopag drug showed a good and precise linearity in the range 2-10 μg/mL. Results: The HPLC, assay showed the purity ranging 99.07 to 100.17% for tablet formulation. The mean percentage purity was 99.76%. The chromatographic retention time of Eltrombopag was found to be 3.10 minutes. The statistical analysis showed the method accuracy. Various forced degradation studies were conducted on Eltrombopag to examine the stability of the drug. The developed method validated as per International Conference on Harmonization (ICH) guidelines. Conclusion: The developed method can be successfully applied for estimation and determination of Eltrombopag in bulk and tablet formulations.
References (7)
- 1 Development of validated stability-indicating assay methods—critical review [DOI]
- 2 Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies [DOI]
- 3 Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers [DOI]
- 4 Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human Subjects [DOI]
- 5 Assessment of the Pharmacokinetic Interaction between Eltrombopag and Lopinavir-Ritonavir in Healthy Adult Subjects [DOI]
- 6 RP-UPLC-MS Assay Method for Eltrombopag: Application in Pharmaceuticals, Human Plasma and Urine Samples [DOI]
- 7 Eltrombopag (Promacta), a Thrombopoetin Receptor Agonist for the Treatment of Thrombocytopenia: Current and Future Considerations [DOI]
Cited by 11
Pranay M. Hadole, Saurabh B. Ganorkar, Suraj R. Chaudhari · Journal of Pharmaceutical Innovation · 2025
Saurabh B. Ganorkar, Shweta S. Sharma, Mangesh R. Patil · Critical Reviews in Analytical Chemistry · 2020
Ajay I PATEL, Shweta GOSAI, Kajal JADAV · Journal of the Turkish Chemical Society Section A: Chemistry · 2020
Pavan Kalyan Regeti, Sunitha B., Parthiban C. · Asian Journal of Pharmaceutical Analysis · 2024
Shabnam Allahverdiyeva, Meryem Çalışır, Ertuğrul Keskin · Diamond and Related Materials · 2020
Showing 5 of 11 known citations — external sources report more than can currently be individually listed.
Related research
- Moisture and Aflatoxin Contents of Kenyan Market Peanuts and Decontamination with Water, Lime and Ultraviolet Radiation Treatments — shares topic coverage
- Enhancement the Biodegradation of Sodium Dodecyl Sulfate by Pseudomonas aeruginosa and Pseudomonas otitidis Isolated from Waste Water in Saudi Arabia — shares topic coverage
- Simultaneous Estimation of Diphenhydramine Hydrochloride and Naproxen Sodium in Raw and Tablet Formulation by Reverse Phase - High-Performance Liquid Chromatographic Method — shares topic coverage
- Isolation and Characterisation of an Isolated Flavonoid from Averrhoa bilimbi — shares topic coverage
- Study of the Photodegradation Kinetics of Fluometuron by UV Absorption Spectrophotometry and Fluorescence — shares topic coverage
Article metrics
Real usage data collected on this platform.
32
Page views
0
PDF downloads
3
Outbound clicks
11
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.